PharmiNews

Directory of Pharma Companies and News

Company Profile

Apaxen

Apaxen logo
Category
Founded in 2018, Apaxen raised €3.3 million in 2019 from a syndicate of Wallonian investors to develop its lead drug candidate (MFC-1040) for treatment of PAH, and to bring forward further drug candidates for treatment of other chronic inflammatory or autoimmune diseases.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma